CELF3
Basic information
Region (hg38): 1:151700058-151716803
Previous symbols: [ "TNRC4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CELF3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 0 |
Variants in CELF3
This is a list of pathogenic ClinVar variants found in the CELF3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-151705100-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
1-151705848-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
1-151705909-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
1-151706324-C-T | Likely benign (Sep 01, 2022) | |||
1-151706347-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
1-151706690-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
1-151706722-G-A | not specified | Uncertain significance (Jun 21, 2022) | ||
1-151707241-C-T | not specified | Uncertain significance (May 16, 2024) | ||
1-151707576-C-T | not specified | Uncertain significance (May 24, 2023) | ||
1-151707796-T-A | Uncertain significance (Oct 22, 2020) | |||
1-151709048-C-T | not specified | Uncertain significance (Apr 09, 2022) | ||
1-151709291-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
1-151714604-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
1-151715887-C-A | not specified | Uncertain significance (May 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CELF3 | protein_coding | protein_coding | ENST00000290583 | 12 | 14411 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.768 | 0.232 | 125741 | 0 | 6 | 125747 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.30 | 121 | 275 | 0.440 | 0.0000163 | 2997 |
Missense in Polyphen | 44 | 110.3 | 0.39892 | 1207 | ||
Synonymous | 1.20 | 102 | 119 | 0.860 | 0.00000810 | 896 |
Loss of Function | 3.90 | 5 | 26.8 | 0.187 | 0.00000150 | 266 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein involved in the regulation of pre- mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Activates the splicing of MAPT/Tau exon 10. Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. {ECO:0000269|PubMed:11158314, ECO:0000269|PubMed:15009664}.;
- Pathway
- Preimplantation Embryo
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.296
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.76
Haploinsufficiency Scores
- pHI
- 0.710
- hipred
- Y
- hipred_score
- 0.711
- ghis
- 0.628
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Celf3
- Phenotype
- reproductive system phenotype;
Gene ontology
- Biological process
- regulation of alternative mRNA splicing, via spliceosome;mRNA splice site selection;spermatogenesis;RNA splicing;flagellated sperm motility;nuclear body organization;positive regulation of mRNA splicing, via spliceosome;ncRNA transcription
- Cellular component
- nucleus;cytoplasm;nuclear body;ribonucleoprotein complex
- Molecular function
- RNA binding;mRNA binding;pre-mRNA binding;7SK snRNA binding